← Back to the blog

Blood Test for Pain: What It Can and Can’t Show

Blood draw in an outpatient laboratory

No routine blood test measures pain itself. But blood work can point to causes behind it, such as inflammation, autoimmune disease, diabetes, thyroid problems or vitamin deficiencies. Newer tests look at immune-system markers linked to chronic pain. This guide covers what standard labs tell you, how to read normal and abnormal results, where research on pain biomarkers stands, and how our test, The Pain Signal Test™, fits in.

Thepaintest
thepaintest.com
Explore Immune Factors Linked to Pain
The Pain Signal Test™ uses a blood draw to assess immune-system factors linked to chronic pain, giving you information to discuss with your healthcare provider.
Learn about the test

TL;DR

  • Standard blood tests (ESR, CRP, rheumatoid factor, anti-CCP, glucose, B12, thyroid) look for causes of pain. They do not measure how much pain you feel.
  • A normal result does not mean your pain is not real. An abnormal one rarely settles a diagnosis alone, because doctors read results alongside your history and exam.
  • Research on blood-based pain biomarkers is promising but still developing, and immune factors are among the most consistently studied.
  • The Pain Signal Test™ is a blood draw that looks at immune-system factors linked to chronic pain. We verify coverage first, and patients with Medicare or PPO insurance typically pay nothing out of pocket.
  • The blood draw itself is usually a brief pinch, not a source of lasting pain.

Table of Contents

What a blood test can and cannot tell you about pain

Pain is an experience, not a single molecule. That is why there is no one number a lab can report as “your pain level.” What blood can do is show signals in the body that help explain why you hurt.

A typical workup asks three questions:

  1. Is there inflammation? Markers like ESR and CRP respond to it.
  2. Is an autoimmune or metabolic condition involved? Rheumatoid factor, anti-CCP, blood sugar and thyroid tests address this.
  3. Is a nutrient or organ problem contributing? Vitamin B12, kidney and liver panels cover this.

The MSD Manual notes that tests should be chosen based on your history and examination, and that white blood cell count, ESR and CRP can help judge the likelihood of inflammatory arthritis but are not highly specific or sensitive. In other words, the lab supports the conversation with your clinician. It does not replace it.

Common blood tests for joint pain and inflammation

If your pain is in your joints, these are the tests you are most likely to meet.

Test What it measures What to know
ESR (sed rate) How fast red blood cells settle in an hour A high result is nonspecific and does not by itself mean autoimmune disease
CRP A protein the liver makes in response to inflammation Cannot pinpoint the cause; some people with RA have normal CRP during flares
Rheumatoid factor An antibody linked to rheumatoid arthritis Can be positive in healthy older adults and in other conditions
Anti-CCP An antibody more specific to rheumatoid arthritis Positive or negative results are not conclusive alone
Uric acid A waste product that can build up in gout May be unreliable during an acute attack

The details behind that table come from several clinical sources. The Arthritis Foundation explains that ESR is nonspecific, and that CRP values of 8 mg/L or 10 mg/L count as high depending on the lab. It also notes that anti-CCP has about 95% specificity, but people with lupus, psoriatic arthritis or active tuberculosis can also test positive, and a negative result does not rule out RA.

Arthritis UK adds that CRP responds more quickly than ESR, normally within days, and that ESR can be influenced by factors such as anemia.

For numbers, the Australian Prescriber reports rheumatoid factor at roughly 70% sensitivity and 80% specificity for rheumatoid arthritis. Anti-CCP has similar sensitivity but specificity above 90%. Low rheumatoid factor titers can show up in healthy people, so a positive result without matching symptoms does not confirm RA.

If you have joint pain, bring your symptom timeline to a primary care doctor or a rheumatologist. They decide which of these tests make sense for you.

Blood tests for nerve pain and neuropathy

Burning, tingling or numb pain in the hands and feet raises a different set of questions. Reviews of laboratory testing for neuropathy, including Horlings and colleagues (2020), list basic screening as a blood cell count, thyroid, kidney and liver function, blood glucose, HbA1c, vitamin B12 and immunofixation.

Lehmann’s 2020 review found that in distal symmetric polyneuropathy the highest yield came from screening for blood glucose and serum protein immunofixation. It also recommends checking B12 metabolites, which are elevated in an additional 5 to 10% of patients whose B12 sits in the lower normal range.

A 2026 article in Frontiers in Neurology describes first-line blood tests for small fiber neuropathy as aimed at metabolic and endocrine causes, plus immunological, inflammatory and infectious ones.

The same Horlings review recommends a stepwise approach rather than ordering everything at once, and referral to a specialized neuromuscular center if first-step tests are negative or inconclusive. That is useful guidance for patients: if your first panel comes back clean and the pain continues, the next step is further evaluation, not giving up.

Blood tests for nerve pain and neuropathy

Why normal results do not mean your pain is imaginary

This is the most common frustration we hear about. Many people with chronic pain have normal basic labs. That does not mean nothing is happening.

A 2024 review by Cook and Buchbinder makes the point clearly: diagnosing inflammatory arthritis rests mainly on history and examination, with lab and imaging results used to support it. Even relatively specific tests, such as anti-CCP or HLA-B27, can be positive in healthy people. A result has to be read in context.

There is also a gap in what gets tested. A 2020 study by Peabody and colleagues found that tests recommended in chronic pain, such as thyroid function, fasting blood sugar and vitamin B12 or B6 levels, were performed less than half the time even when indicated. Markers of oxidative stress and nerve health were often not considered at all.

So two things can be true at once: basic labs miss a lot, and the right panel is not always ordered. Both are reasons to ask your clinician what has and has not been checked.

Where research on pain biomarkers stands

Researchers are working on blood markers that reflect pain biology directly. Here is an honest picture of the field.

  • Inflammatory markers are the most consistent signal. A 2026 umbrella review of 49 systematic reviews found that CRP, IL-6 and TNF-α showed the most consistent associations with chronic musculoskeletal pain. It also concluded that no single biomarker has yet achieved clinical validation for chronic pain.
  • Blood is an attractive sample. A 2025 review by Mackey and colleagues describes blood-based biomarkers as promising because analysis is easy, minimally invasive and low cost, and says moving from exploratory data to clinical use needs validation in large, diverse patient groups.
  • Immune activity shows up in specific conditions. A 2025 study found two potential biological subgroups of CRPS type 1, with different IL-1RA levels, in a small group of 12 women. A 2024 study in the journal Pain found neuroimmune activation in the central nervous system in patients with disk-related back pain, even without systemic inflammation.
  • Gene expression in blood is being explored. A 2019 study identified blood gene expression biomarkers that predicted pain state and future emergency visits for pain.

The direction is consistent: immune and inflammatory biology matters in chronic pain, and blood is a practical way to look at it. That is the idea our test is built around.

What about pain tolerance tests and urine panels?

You may see headlines about a blood test that rates pain tolerance. Those are early-stage research reports, and no routine clinical test gives a pain score today. Insurers are cautious about some proprietary pain panels. Anthem’s medical policy on one urine biomarker panel says its clinical validity and utility have not been established and that no federal regulator has cleared it for this use.

That is why coverage verification matters when you consider any specialized test. We check coverage before you pay for anything, so you know where you stand.

What about pain tolerance tests and urine panels?

The Pain Signal Test™: our approach

The Pain Signal Test™ was developed from peer-reviewed DNA research at a leading U.S. university. It is a simple blood draw that looks at immune-system factors linked to chronic pain, a part of the picture that routine pain workups often leave out.

We designed it to give you and your healthcare provider objective biological information rather than guesswork. It is meant to support a conversation, not to replace your clinician’s judgment, and it works alongside the standard labs described above.

How it works for patients

  1. You order the test directly, or your healthcare provider does.
  2. We verify your coverage. Patients with Medicare or PPO insurance typically pay nothing out of pocket.
  3. You complete a blood draw.
  4. You receive results about immune-related biological markers, to review with your healthcare provider and plan next steps.

For patients who pay out of pocket, FSA and HSA pre-tax medical accounts are payment options. We do not publish a price on our site, so coverage verification is the way to get your specific cost.

Who it is for

The test is built for people living with chronic pain who want objective information: those seeking a diagnosis, those frustrated by treatments that have not helped, and providers looking for innovative testing methods. If your pain involves the neck or head, our blog on neck and head pain causes and warning signs covers the symptoms worth discussing with a clinician.

Our perspective

For years, chronic pain has been treated as a puzzle with missing pieces. Patients cycle through scans, basic labs and trial-and-error prescriptions, and are too often told that everything looks normal.

We think one missing piece is the immune system. The research literature keeps returning to inflammatory and immune signals in chronic pain, and blood is the simplest way to look at them. That is why we built The Pain Signal Test™ on peer-reviewed DNA research from a leading U.S. university.

Our goal is simple. We want patients and providers to start from objective biology instead of guesswork, and we want cost not to be the barrier. Verifying coverage up front, and working with Medicare and PPO plans, is how we try to make that real.

A result is a starting point for a better conversation with your doctor about next steps, and we built the test for that conversation.

the author

Get your coverage checked

If you have been living with pain that standard testing has not explained, The Pain Signal Test™ is a straightforward next step. We verify your coverage first, and eligible Medicare and PPO patients typically pay nothing out of pocket.

Thepaintest

Bring your results to your healthcare provider and use them to choose what comes next.

How to get the most from any pain blood test

  • Write down your symptom timeline before the appointment: where it hurts, when it started, what makes it better or worse.
  • List what has already been tested. Ask whether thyroid, glucose, B12 and inflammation markers were included.
  • Ask what a normal result rules in and out. As the research above shows, many markers are not specific on their own.
  • Plan the follow-up. Results matter most when paired with an exam, imaging if needed, and a clear next step.
  • Report new or severe symptoms promptly. Sudden weakness, loss of bladder or bowel control, or fever with joint swelling need urgent medical attention, not a lab appointment.

Does a blood draw hurt?

For most people, the draw is a brief pinch. A standard blood-draw needle is under a millimeter wide and crosses only a couple of millimeters of skin, and pain varies between people and between days. If you have chronic pain or needle anxiety, tell the person drawing your blood. Staying hydrated and breathing slowly can help, and they can choose a comfortable arm and position.

FAQ

Can a blood test diagnose chronic pain?

No single blood test diagnoses chronic pain. Blood work can identify conditions that cause or contribute to pain, such as inflammatory arthritis, diabetes or B12 deficiency. Clinicians combine those results with your history and exam. Research on dedicated pain biomarkers is active, but no single marker has been clinically validated yet.

What blood tests are used for joint pain?

Common ones are ESR, CRP, rheumatoid factor, anti-CCP and uric acid. Each answers a narrow question, and none is conclusive alone. Your doctor chooses tests based on which joints hurt and what the exam shows.

Does a normal blood test mean nothing is wrong?

No. Routine labs can be normal in people with real, ongoing pain, and some markers stay normal even during flares. If pain continues, ask about further evaluation, including a specialist referral.

How does The Pain Signal Test™ differ from routine labs?

Routine labs mainly look for inflammation, autoimmune disease or metabolic problems. Our test looks at immune-system factors linked to chronic pain, using research from a leading U.S. university. You and your provider can then discuss the results and plan next steps.

Will insurance cover it?

We verify coverage before you pay. Patients with Medicare or PPO insurance typically pay nothing out of pocket. Others can use FSA or HSA funds or pay directly.

Sources

Made with BabyLoveGrowth to grow search and AI visibility